These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 28973659
1. Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline Supplementation. Bagley BD, Chang SC, Ehresman DJ, Eveland A, Zitzow JD, Parker GA, Peters JM, Wallace KB, Butenhoff JL. Toxicol Sci; 2017 Dec 01; 160(2):284-298. PubMed ID: 28973659 [Abstract] [Full Text] [Related]
2. Editor's Highlight: Perfluorooctane Sulfonate-Choline Ion Pair Formation: A Potential Mechanism Modulating Hepatic Steatosis and Oxidative Stress in Mice. Zhang L, Krishnan P, Ehresman DJ, Smith PB, Dutta M, Bagley BD, Chang SC, Butenhoff JL, Patterson AD, Peters JM. Toxicol Sci; 2016 Sep 01; 153(1):186-97. PubMed ID: 27413108 [Abstract] [Full Text] [Related]
3. Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. Butenhoff JL, Chang SC, Olsen GW, Thomford PJ. Toxicology; 2012 Mar 11; 293(1-3):1-15. PubMed ID: 22266392 [Abstract] [Full Text] [Related]
4. Evaluation of hepatic and thyroid responses in male Sprague Dawley rats for up to eighty-four days following seven days of dietary exposure to potassium perfluorooctanesulfonate. Elcombe CR, Elcombe BM, Foster JR, Chang SC, Ehresman DJ, Noker PE, Butenhoff JL. Toxicology; 2012 Mar 11; 293(1-3):30-40. PubMed ID: 22239858 [Abstract] [Full Text] [Related]
7. Perfluorooctane sulfonate-induced changes in fetal rat liver gene expression. Bjork JA, Lau C, Chang SC, Butenhoff JL, Wallace KB. Toxicology; 2008 Sep 29; 251(1-3):8-20. PubMed ID: 18692542 [Abstract] [Full Text] [Related]
8. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Yu WG, Liu W, Jin YH. Environ Toxicol Chem; 2009 May 29; 28(5):990-6. PubMed ID: 19045937 [Abstract] [Full Text] [Related]
13. Perfluorooctane sulfonate increased hepatic expression of OAPT2 and MRP2 in rats. Yu WG, Liu W, Liu L, Jin YH. Arch Toxicol; 2011 Jun 29; 85(6):613-21. PubMed ID: 21046362 [Abstract] [Full Text] [Related]
16. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C. Toxicol Sci; 2003 Aug 29; 74(2):369-81. PubMed ID: 12773773 [Abstract] [Full Text] [Related]
17. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice. Bijland S, Rensen PC, Pieterman EJ, Maas AC, van der Hoorn JW, van Erk MJ, Havekes LM, Willems van Dijk K, Chang SC, Ehresman DJ, Butenhoff JL, Princen HM. Toxicol Sci; 2011 Sep 29; 123(1):290-303. PubMed ID: 21705711 [Abstract] [Full Text] [Related]